Piedmont Healthcare, Vanderbilt, To Use GHX Implantable Device Supply Chain Tool
Global Healthcare Exchange, Louisville, Colo., has announced Piedmont Healthcare, Atlanta, and Vanderbilt University Medical Center, Nashville, Tenn., have signed on to deploy GHX’s Case Xpert platform. GHX says Case Xpert is the healthcare industrys first end-to-end supply chain solution for managing and tracking implantable medical devices, including the physician preference items used in operating rooms.
Global Healthcare Exchange, Louisville, Colo., has announced Piedmont Healthcare, Atlanta, and Vanderbilt University Medical Center, Nashville, Tenn., have signed on to deploy GHX's Case Xpert platform. GHX says Case Xpert is the healthcare industry’s first end-to-end supply chain solution for managing and tracking implantable medical devices, including the physician preference items used in operating rooms.
"Both hospital systems will use Case Xpert to integrate with and leverage existing technology in order to drive out costs, supporting numerous efforts being propelled by healthcare reform," GHX said in a prepared statement announcing the deals.
Case Xpert captures and shares data from case creation to product usage during procedures, creating usage capture capability while validating that the device is on contract for more accurate billing, purchasing and inventory tracking. A software-as-a-service application, the technology is formed around a core set of integration and intelligent routing capabilities in a secure, cloud-based environment. GHX says it enables providers and manufacturers to initiate implantable device cases and track them through audit and completion using agreed upon item and price information maintained in Case Xpert, with HIPAA-compliant security. It also provides the ability to transport PPI orders via the GHX Exchange and automate the review and validation of the information on the order.
GHX says benefits seen in pilot site usage include improved charge capture resulting in less revenue leakage; increase in on-contract spending; decrease in contract overpayment via increase in real-time pricing; increased access to early pay discounts; reduction in documentation errors, case-to-bill cycle time as well as time spent on dispute resolution.
“We’re delighted that Piedmont and Vanderbilt are choosing to lead the healthcare industry by automating their implantable device supply chains,” said Derek Smith, chief commercial officer at GHX. “Implantable devices are on average 30 percent of total hospital supply spend, based on the service line mix, and make up 50-80 percent of the total cost for some procedures, so effectively managing these devices can have a significant impact on the efficiency of healthcare.”
"Both hospital systems will use Case Xpert to integrate with and leverage existing technology in order to drive out costs, supporting numerous efforts being propelled by healthcare reform," GHX said in a prepared statement announcing the deals.
Case Xpert captures and shares data from case creation to product usage during procedures, creating usage capture capability while validating that the device is on contract for more accurate billing, purchasing and inventory tracking. A software-as-a-service application, the technology is formed around a core set of integration and intelligent routing capabilities in a secure, cloud-based environment. GHX says it enables providers and manufacturers to initiate implantable device cases and track them through audit and completion using agreed upon item and price information maintained in Case Xpert, with HIPAA-compliant security. It also provides the ability to transport PPI orders via the GHX Exchange and automate the review and validation of the information on the order.
GHX says benefits seen in pilot site usage include improved charge capture resulting in less revenue leakage; increase in on-contract spending; decrease in contract overpayment via increase in real-time pricing; increased access to early pay discounts; reduction in documentation errors, case-to-bill cycle time as well as time spent on dispute resolution.
“We’re delighted that Piedmont and Vanderbilt are choosing to lead the healthcare industry by automating their implantable device supply chains,” said Derek Smith, chief commercial officer at GHX. “Implantable devices are on average 30 percent of total hospital supply spend, based on the service line mix, and make up 50-80 percent of the total cost for some procedures, so effectively managing these devices can have a significant impact on the efficiency of healthcare.”